| RS1181631215 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS118163237 |
UPB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of beta-ureidopropionase, Deficiency of beta-ureidopropionase |
| RS1181632862 |
NEXMIF
|
Health Risk |
Pathogenic |
X-linked intellectual disability, Cantagrel type |
| RS1181633993 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1181638652 |
FN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondylometaphyseal dysplasia, Spondylometaphyseal dysplasia - Sutcliffe type |
| RS1181644535 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1181648787 |
FAM161A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS1181654735 |
TTC7A
|
Health Risk |
Likely pathogenic |
Gastrointestinal defect and immunodeficiency syndrome, Multiple gastrointestinal atresias |
| RS118166702 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 10, Dilated cardiomyopathy 1J |
| RS1181672712 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1181684993 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS118169528 |
PCCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, Propionic acidemia |
| RS1181703281 |
GORAB
|
Health Risk |
Pathogenic |
— |
| RS1181733510 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS1181742615 |
LAMA3
|
Health Risk |
Pathogenic |
Junctional epidermolysis bullosa, non-Herlitz type |
| RS118174667 |
COLGALT1
|
Health Risk |
Conflicting classifications of pathogenicity |
COLGALT1-related disorder, COLGALT1-related disorder |
| RS118174674 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS118175546 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, TH-related disorder |
| RS1181756021 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Inborn genetic diseases |
| RS1181790213 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1181822928 |
SLC2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1181841660 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1181854686 |
KAT6A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1181863323 |
EIF2AK4
|
Health Risk |
Pathogenic |
Familial pulmonary capillary hemangiomatosis, Familial pulmonary capillary hemangiomatosis |
| RS1181877748 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS118187988 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS118188023 |
NOTCH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hajdu-Cheney syndrome, NOTCH2-related disorder |
| RS1181898358 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS1181901214 |
TMC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 7, Sensorineural hearing loss disorder |
| RS1181915653 |
CTNNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS118192098 |
MT-TK
|
Health Risk |
Pathogenic |
Leigh syndrome, MERRF syndrome |
| RS118192099 |
MT-TK
|
Health Risk |
Likely pathogenic |
MERRF/MELAS overlap syndrome, MERRF syndrome |
| RS118192100 |
MT-TK
|
Health Risk |
Likely pathogenic |
Cardiomyopathy and Deafness, Leigh syndrome |
| RS118192101 |
MT-TK
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial disease |
| RS118192117 |
RYR1
|
Health Risk |
Likely pathogenic |
Congenital myopathy with fiber type disproportion, Central core myopathy |
| RS118192123 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192125 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS118192127 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192129 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192131 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS118192132 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192133 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192134 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192136 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS118192139 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192140 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS118192142 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192143 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS118192144 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192146 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, Central core myopathy |
| RS118192147 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192148 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192149 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192150 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192151 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192153 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192154 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192155 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192156 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192162 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS118192163 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS118192164 |
RYR1
|
Health Risk |
Pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Congenital multicore myopathy with external ophthalmoplegia |
| RS118192165 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192166 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, Malignant hyperthermia of anesthesia |
| RS118192168 |
RYR1
|
Health Risk |
Likely pathogenic |
Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia |
| RS118192169 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192171 |
RYR1
|
Health Risk |
Likely pathogenic |
Neuromuscular disease, congenital |
| RS118192172 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS118192173 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, RYR1-related disorder |
| RS118192174 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital multicore myopathy with external ophthalmoplegia, Clubfoot |
| RS118192175 |
RYR1
|
Health Risk |
Likely pathogenic |
Malignant hyperthermia, susceptibility to |
| RS118192176 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS118192177 |
RYR1
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS118192178 |
RYR1
|
Health Risk |
Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192179 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Central core myopathy, RYR1-related disorder |
| RS118192180 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192181 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS118192183 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, RYR1-related disorder |
| RS118192184 |
RYR1
|
Health Risk |
Pathogenic |
Central core myopathy, Central core myopathy |
| RS118192185 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192186 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS118192188 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192194 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS118192195 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS118192197 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS118192199 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192200 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192201 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192202 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192203 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS118192204 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192205 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS118192206 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192207 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192208 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192209 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS118192211 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS118192212 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizure, Developmental and epileptic encephalopathy |
| RS118192215 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS118192216 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |